PTCT - PTC Therapeutics wins FDA priority review for gene therapy
2024-05-14 08:18:12 ET
More on PTC Therapeutics
- PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript
- PTC Therapeutics, Inc. (PTCT) Q4 2023 Earnings Call Transcript
- PTC Therapeutics GAAP EPS of -$1.20 beats by $0.07, revenue of $210.12M beats by $46.3M
- PTC Therapeutics Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on PTC Therapeutics